Immunotherapy for advanced bladder cancer
29th May 2020
An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Professor Tom Powles.
Read morePersonalised ovarian cancer risk prediction reduces worries
18th May 2020
Offering personalised ovarian cancer risk prediction to women shows that 98 per cent of participants felt less worried after finding out their ovarian cancer risk status, according to a new study.
Read moreMetal analysis of urine for pancreatic cancer detection
28th April 2020
Research has revealed that the signature of metal ions present in urine samples is an accurate indicator of pancreatic ductal adenocarcinoma, one of the deadliest types of cancer.
Read moreOvarian Cancer Awareness Month
26th March 2020
This Ovarian Cancer Awareness Month, we spoke to Professor Fran Balkwill about her work and the challenges we face in the treatment of ovarian cancer.
Read moreThe TME: Key to controlling cancer cell growth
10th March 2020
The tumour microenvironment: Key to controlling cancer cell growth Research led by Barts Cancer Institute (BCI), Queen Mary University of London, reveals novel insights into the role of the tumour […]
Read moreInternational Women’s Day 2020
6th March 2020
In recognition of International Women’s Day on 8th March, we spoke to some of our female scientists about their roles and inspirations.
Read more